In cellular and animal models of AD, gastrodin exhibits multiple mechanisms of action, including the inhibition of BACE1 expression, reduction of tau hyperphosphorylation, and prevention of amyloid‐beta (Aβ) aggregation [12, 18]. The gene discussed is MAPT; the disease is Alzheimer disease.